Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Bimonte, Sabrina ^a   Barbieri, Antonio ^a   Palma, Giuseppe ^a,b   Rea, Domenica ^a   Luciano, Antonio ^a   D'Aiuto, Massimiliano ^a   Arra, Claudio ^a   Izzo, Francesco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD31 ANTIGEN; CURCUMIN; CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; CCND1 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; BIOSYNTHESIS; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TRIPLE NEGATIVE BREAST NEOPLASMS;

CURCUMA LONGA;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; CURCUMIN; CYCLIN D1; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; TRIPLE NEGATIVE BREAST NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84927144570     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/878134     Document Type: Article

References (36)

1. M.-T. Park, M.-J. Kim, Y.-H. Kang et al., "Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROSdependent and -independent AIF release", Blood, vol. 105, no. 4, pp. 1724-1733, 2005.
2. N. Eckstein, "Platinum resistance in breast and ovarian cancer cell lines", Journal of Experimental and Clinical Cancer Research, vol. 30, no. 1, article 91, 2011.
3. Z. Jiang, J. Guo, J. Shen, M. Jin, S. Xie, and L. Wang, "The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells", Journal of Experimental and Clinical Cancer Research, vol. 31, no. 1, article 42, 2012.
4. C. Marquette and L. Nabell, "Chemotherapy-resistantmetastatic breast cancer", Current Treatment Options in Oncology, vol. 13, no. 2, pp. 263-275, 2012.
5. G. Yan, K. Graham, and S. Lanza-Jacoby, "Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells", Molecular Carcinogenesis, vol. 52, no. 5, pp. 404-411, 2013.
6. A. B. Kunnumakkara, P. Anand, and B. B. Aggarwal, "Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins", Cancer Letters, vol. 269, no. 2, pp. 199-225, 2008.
7. S. M. Gao, J. J. Yang, C. Q. Chen et al., "Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells", Journal of Experimental and Clinical Cancer Research, vol. 31, article 27, 2012.
8. C. A. Reddy, V. Somepalli, T. Golakoti et al., "Mitochondrialtargeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin", PLoS ONE, vol. 9, no. 3, Article ID e89351, 2014.
9. G. Ji, J. Yang, and J. Chen, "Preparation of novel curcuminloaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy", International Journal of Pharmaceutics, vol. 466, no. 1-2, pp. 314-320, 2014.
10. M. Farazuddin, B. Dua, Q. Zia, A. A. Khan, B. Joshi, and M. Owais, "Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals", International Journal of Nanomedicine, vol. 9, pp. 1139-1152, 2014.
11. Y. Zhan, Y. Chen, R. Liu, H. Zhang, and Y. Zhang, "Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling", Archives of Pharmacal Research, vol. 37, no. 8, pp. 1086-1095, 2014.
12. Y. Yu, X. Zhang, and L. Qiu, "The anti-tumor efficacy of curcumin when delivered by size/charge-changing multistage polymeric micelles based on amphiphilic poly (β-amino ester) derivates", Biomaterials, vol. 35, no. 10, pp. 3467-3479, 2014.
13. D. Liu and Z. Chen, "The effect of curcumin on breast cancer cells", Journal of Breast Cancer, vol. 16, no. 2, pp. 133-137, 2013.
14. A. Garufi, D. Trisciuoglio, M. Porru et al., "A fluorescent curcumin-based Zn (II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells", Journal of Experimental and Clinical Cancer Research, vol. 32, no. 1, article 72, 2013.
15. S. Bimonte, A. Barbieri, G. Palma, A. Luciano, D. Rea, and C. Arra, "Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer", Bio Med Research International, vol. 2013, Article ID 810423, 8 pages, 2013.
16. T.-L. Chiu and C.-C. Su, "Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappa Bp65 expression in breast cancer MDA-MB-231 cells", International Journal of Molecular Medicine, vol. 23, no. 4, pp. 469-475, 2009.
17. Q. Liu, W. T. Y. Loo, S. C. W. Sze, and Y. Tong, "Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cellsmediated by down-regulation of NFκB, cyclin D and MMP-1 transcription", Phytomedicine, vol. 16, no. 10, pp. 916-922, 2009.
18. H. Zong, F. Wang, Q.-X. Fan, and L.-X. Wang, "Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NFkappa B signaling pathways", Molecular Biology Reports, vol. 39, no. 4, pp. 4803-4808, 2012.
19. H. J. Kang, S. H. Lee, J. E. Price, and L. S. Kim, "Curcumin suppresses the paclitaxel-induced nuclear factor-B in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model", Breast Journal, vol. 15, no. 3, pp. 223-229, 2009.
20. M. Narasimhan and S. Ammanamanchi, "Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells", Cancer Research, vol. 68, no. 13, pp. 5185-5192, 2008.
21. H.-W. Lai, S.-Y. Chien, S.-J. Kuo et al., "The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison studywith herceptin", Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID486568, 12 pages, 2012.
22. G. Chakraborty, S. Jain, S. Kale et al., "Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression", Molecular Medicine Reports, vol. 1, no. 5, pp. 641-646, 2008.
23. C. E. Carroll, M. R. Ellersieck, and S. M. Hyder, "Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells", Menopause, vol. 15, no. 3, pp. 570-574, 2008.
24. Y. H. Soung and J. Chung, "Curcumin inhibition of the functional interaction between integrin alpha6beta4 and the epidermal growth factor receptor", Molecular Cancer Therapeutics, vol. 10, no. 5, pp. 883-891, 2011.
25. S. S. Chung and J. V. Vadgama, "Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via downregulation of STAT3-NFκB signaling", Anticancer Research, vol. 35, no. 1, pp. 39-46, 2015.
26. T. Jia, L. Zhang, Y. Duan et al., "The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway", Cancer Cell International, vol. 14, article 126, 2014.
27. M. Yamaguchi, S. Zhu, S. Zhang et al., "Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mousemodel: involvement in osteoblastogenesis and osteoclastogenesis", Cell and Tissue Research, vol. 357, no. 1, pp. 245-252, 2014.
28. Z. D. Lv, X. P. Liu, W. J. Zhao et al., "Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo", International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 2818-2824, 2014.
29. D. V. Singh, S. Agarwal, P. Singh, M. M. Godbole, and K. Misra, "Curcumin conjugates induce apoptosis via a mitochondrion dependent pathway in MCF-7 and MDA-MB-231 cell lines", Asian Pacific Journal of Cancer Prevention, vol. 14, no. 10, pp. 5797-5804, 2013.
30. N. Mo, Z.-Q. Li, J. Li, and Y.-D. Cao, "Curcumin inhibits TGFbeta1-induced MMP-9 and invasion through ERK and smad signaling in breast cancer MDA-MB-231 cells", Asian Pacific Journal of Cancer Prevention, vol. 13, no. 11, pp. 5709-5714, 2012.
31. N. Cine, P. Limtrakul, D. Sunnetci, B. Nagy, and H. Savli, "Effects of curcumin on global gene expression profiles in the highly invasive human breast carcinoma cell line MDA-MB 231: a gene network-based microarray analysis", Experimental and Therapeutic Medicine, vol. 5, no. 1, pp. 23-27, 2013.
32. X. D. Sun, X. E. Liu, and D. S. Huang, "Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression", Molecular Medicine Reports, vol. 6, no. 6, pp. 1267-1270, 2012.
33. A. B. Kunnumakkara, S. Guha, S. Krishnan, P. Diagaradjane, J. Gelovani, and B. B. Aggarwal, "Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products", Cancer Research, vol. 67, no. 8, pp. 3853-3861, 2007.
34. B. B. Aggarwal, S. Shishodia, Y. Takada et al., "Curcumin suppresses the paclitaxel-induced nuclear factor-kappa B pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice", Clinical Cancer Research, vol. 11, no. 20, pp. 7490-7498, 2005.
35. H. J. Lewerenz, "J. E. Harknessund J. E. Wagner: the biology and medicine of rabbits and rodents. 152 Seiten. Lea and Febinger, Philadelphia 1977. Preis: 8, - $", Food/Nahrung, vol. 23, no. 1, p. 99, 1979.
36. P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, "Bioavailability of curcumin: problems and promises", Molecular Pharmaceutics, vol. 4, no. 6, pp. 807-818, 2007.